Release Date: 30/09/22 16:16 Summary: Updated Estimated Distribution Announcement - Sep 2022 Price Sensitive: Yes Download Document 72.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%